Sonavex, Inc. — SEC Form D Filing
Sonavex, Inc. filed an SEC Form D on July 28, 2026, reporting $3.10M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 28, 2026
- Amount reported
- $3.10M
- Industry
- Medical Devices
- Website
- https://www.sonavex.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Clinicians need more accurate and automated ways to monitor and visualize critical data for dialysis access care, particularly for fistula maturation and cannulation guidance, which are currently manual and less precise.
Solution
Sonavex provides automated 3D ultrasound solutions to dialysis access care teams, which quantify and visualize critical clinical data to inform treatment decisions and improve patient care.
Verdict
Investors funded Sonavex because the quantitative imaging narrative could enable more predictable clinical outcomes in a prevalent chronic condition, not because it promised a disruptive shift in diagnostic paradigms. The implicit bet was on healthcare systems prioritizing incremental precision gains to reduce costly complications. Durability was limited by the need for clinical workflow integration and the slow adoption cycles inherent to hardware-dependent medical device innovation.
Source: SEC EDGAR Form D filing